Table 4.
Noradrenaline turnover in each part of the brain.
| Brain region | Group | Turnover | |
|---|---|---|---|
| NM/noradrenaline | MHPG/noradrenaline | ||
| Striatum | Control | -- | 20.62 ± 3.14 |
| Exposed | -- | 14.44 ± 2.15 | |
| Hippocampus | Control | 0.069 ± 0.006 | 4.59 ± 0.35 |
| Exposed | 0.074 ± 0.007 | 2.97 ± 0.24** | |
| Midbrain | Control | 0.034 ± 0.002 | 1.84 ± 0.11 |
| Exposed | 0.028 ± 0.003 | 1.12 ± 0.06** | |
| Cerebellum | Control | 0.145 ± 0.011 | 10.82 ± 1.30 |
| Exposed | 0.131 ± 0.013 | 6.87 ± 0.36* | |
| Brainstem | Control | 0.0568 ± 0.003 | 0.415 ± 0.015 |
| Exposed | 0.0487 ± 0.003 | 0.380 ± 0.030 | |
Data are presented as mean ± SEM (n = 10 per group). The statistical significance is shown as *P < 0.05, **P < 0.01; ND, not detectable. Abbreviations: MHPG, 4-hydroxy-3-methoxyphenylglycol; NM, normetanephrine.